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Effects of 3D nanocomposite bioceramic scaffolds on 
the immune response 
Mónica Cicuéndeza,b, Pilar Portolésc,d, María Montes-Casadod, Isabel 
Izquierdo-Barbaa,b, María Vallet-Regía,b*and María Teresa Portolése*  
The interaction of new nanocomposite mesoporous glass/hydroxyapatite (MGHA) scaffolds 
with immune cells involved in both innate and acquired immunity has been studied in vitro as 
an essential aspect of their biocompatibility assessment. Since the immune response can be 
affected by the degradation products of bioresorbable scaffolds and scaffold surface changes, 
both processes have been evaluated. No alterations in proliferation and viability of RAW-264.7 
macrophage-like cells were detected after culture on MGHA scaffolds which did not induce 
cell apoptosis. However, a slight cell size decrease and intracellular calcium content increase 
were observed after contact of this cell line with MGHA scaffolds or their extracts. Although 
no changes on the percentages of RAW cells with low and high content of reactive oxygen 
species (ROS) are observed by treatment with 7d extracts, this study has revealed 
modifications of these percentages after direct contact with scaffolds and by treatment with 
24h extracts, related to the high reactivity/bioactivity of this MGHA nanocomposite at initial 
times. Furthermore, when normal fresh murine spleen cells were used as an experimental 
model closer to physiological conditions, no significant alterations in the activation of different 
immune cell subpopulations were detected in the presence of 24h MGHA extract. MGHA 
scaffolds did not affect the spontaneous apoptosis or intracellular cytokine expression (IL-2, 
IL-10, IFN-γ, TNF-α) either after 24h treatment. The results obtained in the present study with 
murine immune cell subpopulations (macrophages, lymphocytes B, lymphocytes T and natural 
killer cells) supports the biocompatibility of MGHA material and suggests an adequate host 
tissue response to their scaffolds upon their implantation.  
1. Introduction 
Tissue engineering, due to its highly multidisciplinary nature, 
needs the combination of clinical medicine, mechanical 
engineering, materials science, genetics, and related disciplines 
from both engineering and life sciences.1 This field relies on the 
use of porous 3D scaffolds to provide the appropriate 
environment for the regeneration of tissues and organs.2 These 
scaffolds essentially act as a template for tissue formation and 
are seeded with cells and occasionally growth factors. The 
combination of cells, biomolecules and scaffolds constitute the 
tissue engineering triad.3  
 The composition, macroporous architecture, microporosity, 
surface topography and chemistry, as well as the mechanical 
properties of scaffolds used for tissue engineering play a crucial 
role in the success rates of implants.3 Fundamental aspects in 
the manufacturing process of 3D scaffolds are the starting 
material and the methodology which must be used for 
configuring the 3D structure. Different biomaterials are 
employed in the fabrication of scaffolds for tissue engineering, 
with specific advantages and disadvantages. Recently, the use 
of composite scaffolds allows improving their properties due to 
the synergy of the features of their components. For this reason, 
composite scaffolds are widely used for different applications.4-
8
 In this sense, our research group have recently synthesized a 
novel nanocomposite material formed by nanocrystalline 
apatite uniformly embedded into a mesostructured SiO2–CaO–
P2O5 glass wall (MGHA material).9 The response of L929 
fibroblasts and Saos-2 osteoblasts to this 
powdered nanocomposite has been previously studied, 
demonstrating a significant improved biocompatibility in 
comparison with conventional mesoporous glasses.9,10 
Furthermore, recently 3D scaffolds based on this 
nanocomposite material have been exhibited a good 
preosteoblast cell adhesion, colonization, proliferation and 
differentiation, suggesting their great potential application in 
bone tissue engineering.11   
 The first characteristic of any scaffold for tissue engineering 
is that it must be biocompatible, allowing the cell adhesion, 
proliferation and migration through it.12,13 However, the 
ultimate functional success or failure of the scaffolds after 
implantation, depends invariably on the host tissue response 
and therefore, the scaffold must not induce immune reaction 
which might reduce healing or produce rejection by the body. 
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Thus, the in vitro evaluation of the biomaterial effects on 
immune system is an essential aspect of biocompatibility 
assessment.14 The immune response comprises both innate and 
adaptive defence mechanisms which activate different cell 
populations co-ordinately. The innate response involves the 
action of neutrophils, monocytes and macrophages which carry 
out phagocytosis and produce reactive oxygen species, 
antimicrobial peptides, and inflammatory mediators.15 Natural 
killer (NK) cells also play a role in the innate response by 
directly killing virus-infected or transformed cells without prior 
priming by secretion of cytotoxic molecules and cytokines.16 
The adaptive response is mediated by antigen-specific 
lymphocytes (T and B cells) which produce inflammatory 
cytokines and antibodies.15 Largely, the interaction of these 
host immune cells with biomaterials has negative implications 
for tissue remodelling. For decades, the interaction of 
macrophages with newly deposited extracellular matrix, 
accompanied by an angiogenic response, has been interpreted 
as a precursor of granulation tissue formation, the classic 
foreign body reaction, with negative implications for 
outcomes.17 However, it has been recently shown that 
macrophages may be beneficial for biomaterial integration 
improving implant performance due to a remarkable functional 
plasticity. Thus, macrophages can play both positive and 
negative roles in disease processes and tissue remodeling, 
presenting a phenotypic spectrum based on three fundamental 
homeostatic activities, including host defence, wound healing, 
and immune regulation.18 There are two extremes of possible 
macrophage phenotypes based on in vitro treatment with 
particular stimuli: proinflammatory (M1) and reparative 
(M2),17-20 whose balance determine the host response to 
biomaterials, with participation of diverse specific cytokines. 
 In this sense, the design of biomaterials capable of 
modulating immune cell function has been suggested in order 
to obtain appropriate host responses at implantation site.16-22 
 Given the excellent biocompatibility and bioactivity shown 
by the MGHA nanocomposite and taking into account its 
potential application in bone tissue engineering,9,11 the present 
study is focused on the in vitro interaction of 3D MGHA 
scaffolds with immune cells involved in both innate and 
acquired immunity. Furthermore, since the immune response 
can be additionally affected by the degradation products of 
bioresorbable scaffolds, the possible cytotoxic effects caused by 
MGHA extracts obtained at different times have been also 
studied. 
 
2. Materials and Methods 
2.1. Preparation of MGHA 3D scaffolds  
MGHA 3D scaffolds based on highly mesostructured 
nanocomposite material were prepared by rapid prototyping 
(RP) using methylcellulose (MC), as previously reported.11 
Once fabricated, these MGHA scaffolds were sterilized under 
UV light for 30 min and then submerged in Dulbecco´s 
Modified Eagle´s Medium (DMEM) supplemented with 
penicillin (800 µg/mL), streptomycin (800 µg/mL), under a CO2 
(5%) atmosphere at 37ºC for 24 h to stabilize before cell 
culture. 
 
2.2. Characterization of MGHA 3D scaffolds  
X-ray diffraction (XRD) experiments were performed on a 
Philips X'Pert diffractometer (Eindhoven, The Netherlands), 
equipped with Cu Kα (40 kV, 20 mA). Transmission electron 
microscopy (TEM) was performed on a JEOL 3010 electron 
microscope (Jeol Ltd., Japan) operating at 300 kV (Cs; 0.6 mm, 
resolution 1.7 Å). All TEM images were recorded employing a 
CCD camera (MultiScan model 794, Gatan Inc., UK) under 
low-dose conditions. Fourier transform (FT) patterns were 
extracted from the images of thin crystal regions using a Digital 
Micrograph (Gatan Inc., UK). Scanning electron microscopy 
(SEM) was performed using a field emission JEOL JSM-6335F 
microscope (Tokyo, Japan) at an acceleration voltage of 10 kV. 
The textural properties of samples were determined by N2 
adsorption porosimetry using a Micromeritics ASAP2020 
analyzer (Norcross, USA). The surface area was determined 
using the multipoint Brunauer–Emmett–Teller method included 
in the software. The porosity of 3D scaffolds was measured by 
mercury intrusion porosimetry in a MicromeriticsAutopore IV 
9500 device (Micromeritics Instrument Corporation, Norcross, 
GA, USA). Elemental analyses (C, H, N) were carried out on a 
LECO CHNS-932 microanalyzer (Saint Joseph, Michigan 
USA). Fourier transform Infrared (FTIR) spectroscopy was 
performed in a Thermo Nicolet Nexus spectrometer (Thermo 
Scientific, USA) from 4000 to 400 cm-1, using the KBr pellet 
method and operating in transmittance mode. 
 
2.3. In vitro degradation of MGHA 3D scaffolds and 
preparation of MGHA extracts  
MGHA scaffolds of ca. 23-25 mg, were immersed at different 
time periods during 30 days in a total volume of 100 mL of 
DMEM supplemented with 10% fetal bovine serum (FBS) and 
antibiotics (100 U ml-1 penicillin, 100 mg ml-1 streptomycin), in 
a Ecotron at 37ºC and 150 r.p.m. The supernatants obtained 
after 24h and 7d, named E 24h and E 7d, were selected for 
immune response studies. These extracts were filtered and 
added to RAW-264.7 macrophage-like cells to evaluate any 
potential cytotoxic effect. Determination of Si (IV), Ca (II) and 
P(V) variations in these extracts were carried out after different 
time intervals by inductively coupled plasma/optical emission 
spectrometry (ICP/OES) in a Perkin Elmer OPTIMA 3300 DV 
device. The scaffold surface was evaluated by scanning 
electron microcopy (SEM) after different times. 
 
2.4. Culture and treatment of RAW-264.7 macrophage-like 
cells 
Murine RAW-264.7 macrophage-like cells were seeded at a 
density of 105 cells/mL in culture medium supplemented with 
10% FBS, 1 mM L-glutamine, penicillin, streptomycin, under a 
5% CO2 atmosphere, at 37ºC for 24h. Extract 24h and 7d have 
been also added to RAW macrophage-like cells to know the 
effects of the released products during the degradation process. 
Then, the attached cells were harvested with PBS/1mM EDTA 
at 4ºC and counted with a Neubauer hemocytometer.  Cell 
suspensions were centrifuged at 310xg for 10 min and 
resuspended in fresh medium for the analysis of different 
parameters by Flow Cytometry as described below (sections 
2.5-2.8). Controls without treatment were carried out in 
parallel. 
 
2.5. Cell cycle analysis and apoptosis detection  
After detachment of RAW-264.7 macrophage-like cells, cell 
suspensions were incubated with Hoechst 33258 (5 µg/ml, 
ethanol 30%, and BSA 1% in PBS), used as nucleic acid dye, 
for 30 min at room temperature in darkness. The fluorescence 
of Hoechst was excited at 350 nm and the emitted fluorescence 
was measured at 450 nm in a LSR Becton Dickinson Flow 
Cytometer. The cell percentage in each cycle phase (G0/G1, S 
and G2/M) was calculated with the CellQuest Program of 
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Becton Dickinson and the SubG1 fraction (cells with 
fragmented DNA) was used as indicative of apoptosis. 
 
2.6. Cell size and complexity 
After detachment of RAW-264.7 macrophage-like cells, 
forward angle (FSC) and side angle (SSC) scatters were 
evaluated as indicative of cell size and complexity respectively 
using a FACScalibur Becton Dickinson flow cytometer. 
 
2.7. Intracellular reactive oxygen species (ROS) content and 
cell viability  
After detachment of RAW-264.7 macrophage-like cells, cell 
suspensions were incubated with 100µM 2´,7´-
dichlorofluorescein diacetate (DCFH/DA) at 37°C for 30 min. 
DCF fluorescence was excited at 488 nm and measured with a 
530/30 nm band pass filter in a FACScalibur Becton Dickinson 
flow cytometer. Cell viability was determined by addition of 
propidium iodide (PI; 0.005% in PBS).  
 
2.8. Intracellular calcium content  
After detachment of RAW-264.7 macrophage-like cells, cell 
suspensions were incubated with the probe Indo-1 AM at a 
concentration of 10 µM for 30 min at room temperature, 
darkness, and shaking. The fluorescence of Indo-1 was excited 
at 325 nm and the emitted fluorescence was measured with 380 
nm long pass (FL1) and 424/44 nm band pass (FL2) filters in a 
LSR Becton Dickinson flow cytometer. After all the 
measurements, 10 µM A-23187 ionophore (Enzo Life Sciences) 
was added in order to prove the sensitivity of the assay. 
 
2.9. Morphological studies by Confocal Microscopy  
For Confocal Microscopy studies, RAW-264.7 macrophage-
like cells were cultured for 24 h on MGHA disks (10 mm 
diameter and 4 mm high) prepared by uniaxial and isostatic 
pressure of powder. After fixation with 3.7% paraformaldehyde 
in PBS for 10 min, samples were washed with PBS and 
permeabilized with 0.1% Triton X-100 for 3 to 5 min. The 
samples were then washed with PBS and preincubated with 
PBS containing 1% BSA for 20 to 30 min. Then cells were 
incubated for 20 min with FITC phalloidin which stains F-actin 
filaments. Samples were then washed with PBS and the cell 
nuclei were stained with DAPI (4′-6-diamidino-2′-
phenylindole, 3 µM in PBS). After staining and washing with 
PBS, cells were examined by a LEICA SP2 Confocal Laser 
Scanning Microscope. The fluorescence of FITC was excited at 
488 nm and the emitted fluorescence was measured at 491-586 
nm. The fluorescence of DAPI was excited at 405 nm and 
measured at 420-480 nm. 
 
2.10. Mice  
Mice from C57BL/6 strain were bred under specific pathogen-
free conditions in the animal care facility of the Centro 
Nacional de Microbiología (Instituto de Salud Carlos III, 
Majadahonda, Madrid, Spain), from stock purchased from 
Charles River. Sex-matched, 10–12 weeks old mice were used 
throughout the experiments. All procedures were approved by 
Institutional Animal Care and Use Committees. 
 
2.11. Culture and activation of murine spleen cells  
Cell suspensions from C57Bl/6 spleens in Click´s culture 
medium supplemented with 10% FBS were obtained, and the 
erythrocytes were lysed by hypotonic shock. Cell suspensions 
were filtered through 30 microns mesh and washed.  In vitro 
primary stimulation was performed by culturing 5x105 cells in 
200 µl of Click´s medium supplemented with 10% FBS and 
10mM HEPES, in the presence of Y-CD3-1  (anti-CD3 
monoclonal antibody, 5 µg/ml)23 or Lipopolysaccharide (LPS, 
E.coli 055:B5, 25 µg/ml) as stimuli and in the presence or 
absence of filtered MGHA extracts. After 3d culture at 37ºC 
and 5% CO2, viability measured as mitochondrial activity was 
assessed by a colorimetric assay using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) as a substrate for 
mitochondrial dehydrogenases in living cells as previously 
described  by Mosmann.24 
 
2.12. Detection of murine lymphocyte spontaneous 
apoptosis 
To assess the effect of MGHA scaffolds on murine lymphocyte 
spontaneous apoptosis, spleen cells were prepared as above but 
cells were cultured in flat-bottom P-48 culture plates containing 
previously stabilized scaffolds. 5 x 106 cells were seeded onto 
the scaffold in a final volume of 0.5 ml culture medium. After 
24h culture at 37ºC and 5% CO2, cells were collected and 
spontaneous apoptosis was determined by Flow Cytometry in 
cells stained with AnnexinV-FITC and propidium iodide using 
the Human Annexin V-FITC kit (eBioscience) according to the 
manufacturer’s instructions and analyzed in a FacsCanto (B-D 
Biosciences) flow cytometer with DIVA software. 
 
2.13. Analysis of intracellular cytokine expression 
To analyze the effect of MGHA scaffolds on cytokine 
expression, suspensions of murine spleen cells were prepared as 
above. 106 cells were seeded onto scaffolds in P-48 culture 
plates and cultured 3d in the presence of Y-CD3-1 (anti-CD3 
antibody, 5 µg/mL) or LPS (50 µg/ml) or culture medium, in 1 
ml final volume. After this time, cells were collected and 
processed for intracellular cytokine detection by Fluorescence-
activated cell sorting (FACS). Intracellular cytokine staining 
was performed essentially as described by Rojo et al.25 Cells 
were washed and re-suspended at 2 x 106 /ml in culture medium 
and stimulated with 20ng/ml phorboldibutyrate (PDB; Sigma-
Aldrich) plus 1 µM ionomycin (Calbiochem) for 1.5h. 
Brefeldin A (10 µg/ml; Sigma-Aldrich) was added, and the 
cells were incubated for further 3.5h, washed and surface 
labeled with desired antibodies  by incubation for 30 min on ice 
with fluorocrome-coupled antibodies diluted in cold staining 
buffer (PBS containing 2% FCS and 0.1% sodium azide). Then, 
the cells were washed two times and fixed for 5 min at room 
temperature with 4% paraformaldehyde in PBS. After stopping 
the fixation with ice-cold 0.1% BSA in PBS/0.1% azide, the 
cells were washed with 0.1% saponin (Sigma-Aldrich) in 
PBS/0.1% BSA/10mM HEPES/azide (PBS/saponin) and 
blocked at 4ºC for 30 min with 5% non-fat milk in 
PBS/saponin. Then, the cells were stained with PE-, Alexa 
Fluor 647-, DyLight 649 (Pierce)- or FITC-coupled antibodies 
in 5% non-fat milkin PBS/saponin for 30 min in the cold. After 
washing three times with PBS/saponin, the cells were analyzed 
in a FACSCanto (B-D Biosciences) flow cytometer. The 
antibodies for cytokine intracellular detection were from 
eBioscience: PE-coupled anti-IL-2 (JES6-5H4), and anti-IL-10 
(JES5-16E3); FITC-coupled anti-IFNγ (XMG 1.2) and anti-
TNFα. As negative controls, PE- or FITC-conjugated isotype 
control mAb were used. 
 
2.14. Statistics  
Data are expressed as means + standard deviations of a 
representative of three experiments carried out in triplicate. 
Statistical analysis was performed using the Statistical Package 
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for the Social Sciences (SPSS) version 19 software. Statistical 
comparisons were made by analysis of variance (ANOVA). 
Scheffé test was used for post hoc evaluations of differences 
among groups. In all of the statistical evaluations, p < 0.05 was 
considered as statistically significant. 
 
3. Results and discussion 
3.1. MGHA 3D scaffolds 
 The new mesoporous glass/hydroxyapatite nanocomposite 
MGHA has been used as starting material for the 
manufacturing of the 3D scaffolds by RP technique, as 
previously has been reported.11 Previous results demonstrate its 
high biocompatibility and bioactivity9,11 and drug loading 
capability,26 characteristics which make to MGHA a potential 
biomaterial for bone tissue engineering. In the present study, 
hierarchical 3D MGHA scaffolds and their degradation 
products (extracts) have been prepared to evaluate their effects 
on immune cells, involving macrophages and lymphocytes.  
 As it can be observed in Fig. 1, MGHA 3D scaffolds 
present a hierarchical porous macro-mesoarchitecture which 
improves cell adhesion, proliferation differentiation and 
colonization.11  
 
 
Fig. 1 SEM and TEM studies of the macro and mesostructure of 
MGHA 3D scaffolds. (A) Cross section of a 3D scaffold showing the 
hierarchical pore structure of MGHA scaffolds. The small arrow shows 
the interconnections of large channels of 400 µm with the interior. (B) 
SEM micrograph taken with a JEOL JSM7600F of 3D scaffold surface, 
showing mesoporous channels typical of a 2D hexagonal structure. (C) 
TEM image showing a mesoporous arrangement, where the darker 
zones homogeneously distributed into the mesoporous channels 
correspond to apatite nanocrystalline phase. 
Moreover, these porosity properties can lead to mineralization, 
vascularisation and nutrient diffusion which are critical for the 
osteogenesis.27-29 Furthermore, the mesoporous arrangement 
could lead an added value as controlled delivery systems of 
biologically active molecules.30,31  
 With the aim of evaluating the in vitro degradation of 
MGHA 3D scaffolds, the surface changes and the evolution of 
their macroporous structure after different incubation times in 
culture medium have been studied by SEM (Fig. 2). In the first 
24h, the SEM micrographs (Fig. 2D, 2E and 2F) show an early 
gradual degradation of the surface with small deposits of 
particles. 
 
Fig. 2 In vitro degradation test. SEM micrographs at different 
magnifications and EDS analyses (inset) before (A, B and C) and after 
1 (D, E and F) and 7 days (G, H and I) soaking in DMEM.  
 Fig. 3 shows in details this gradual deposition which is 
formed by needled-like particles typical of apatite formation on 
bioactive surfaces.29 On the other hand, after 7d, there are 
substantial changes in the surface and the macroporous 
architecture of the scaffold (Fig. 2G and 2H), showing a 
notable degradation from a smooth surface (in situ) to a highly 
degraded surface which exhibits macroporous in the range of 
100-25µm. Moreover, SEM higher magnification (Fig. 2I) 
shows the existence in this surface of acicular particles with a 
majority composition of Ca and P (Ca/P =1.67), corresponding 
to apatite phase, in agreement with other studies.32 EDS 
analyses (inset Fig. 2C, 2F and 2I) confirm both notable 
increase of the amount Ca and P together with a decrease of Si 
amount in the scaffold surface after 1 and 7d of incubation in 
DMEM, respectively (Fig. 4). These results evidence the 
excellent bioactive behaviour, according to previous results in 
simulated body fluid.9  
 Fig. 4 shows a gradual degradation of 3D scaffolds, 
exhibiting an initial rapid increase of calcium and phosphorus 
concentration in the soaking medium in the first 24h of 
incubation. Then, the ionic concentrations slightly increase 
until 7d and remain without variation until 30d. Concerning the 
silicon variation, the plot shows constant gradual silicon 
leaching during all period time. Thus, the obtained results 
reveal a gradual degradation of these 3D MGHA scaffolds over 
time.  
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Fig. 3 SEM study of MGHA scaffolds before and after 24 hours of 
incubation in DMEM. The micrographs show clearly the formation of 
needled-like aggregated of apatite phase on the scaffolds surface after 
24h.  
 
Fig. 4 Variation of the Calcium, Phosphorous and Silicon 
concentration in DMEM overtime.  
 FTIR spectroscopy was carried out to evaluate the changes 
in the MGHA nanocomposite scaffold surface as a function of 
soaking time in DMEM (Fig. 5). Before soaking, the spectrum 
shows characteristic absorption bands of Si-O bonds at 1040, 
800, and 470 cm-1. After 24 hours of soaking in DMEM, an 
increase of the doublet at 560 and 600 cm-1, corresponding to a 
crystalline phosphate is observed, confirming the formation of a 
new crystalline phosphate onto the scaffold surface in 
agreement to SEM-EDS results. Moreover, after 7d, the 
spectrum analysis shows clearly the proteins adsorption derived 
of completed DMEM onto the MGHA surface formed onto 
newly apatite layer.  
 
 
Fig. 5 FTIR spectra corresponding to MGHA scaffolds before and 
after 24h and 7d in DMEM.  
 To evaluate in vitro the response of immune cells to MGHA 
scaffolds, RAW-264.7 macrophage-like cells and murine spleen 
cells have been cultured in contact with these samples or their 
extracts (obtained after 24h and 7d as described above in 
section 2.3). These incubation times have been chosen taking 
into account the higher reactivity of MGHA material at 24h and 
the scaffold degradation/bioactivity observed after 7d.  
3.2. Effects of MGHA biomaterial on RAW-264.7 
macrophage-like cells 
RAW-264.7 macrophage-like cells are functional macrophages 
with the ability of autophagy and phagocytosis as immune cells 
and retain many of the characteristics of macrophages in vivo, 
for these reasons this cell line is usually used for in vitro 
biocompatibility studies.33 Table I shows that no significant 
changes of cell viability (up 75 %) were detected by propidium 
iodide exclusion test after 24h culture of RAW-264.7 
macrophage-like cells with MGHA extracts (obtained at 24h 
and 7d; E 24h and E 7d, respectively) or MGHA scaffolds 
(SC). 
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Table I. Effect of MGHA extracts (obtained at 24h and 7d) and MGHA 
scaffolds (SC) on viability of RAW-264.7 macrophage-like cells after 
24h treatment. Cells without treatment were cultured in parallel 
(Control). 
Sample Viability (%) 
Control 79.3 ± 2.2 
E 24h 78.8 ± 2.8 
E 7d 82.1 ± 3.4 
SC 75.8 ± 2.1 
 
 When proliferation of RAW-264.7 macrophage-like cells on 
MGHA scaffolds was evaluated, no alterations were detected in 
comparison with control samples (Table II). The cell cycle was 
studied by flow cytometry after culture of these cells on MGHA 
scaffolds and the SubG1fraction, attributed to cells with 
fragmented DNA, was used as indicative of apoptosis.34 Viable 
cell number count was used to assess proliferation. As it can be 
observed in Table II, MGHA samples did not produce changes 
in SubG1 phase of RAW-264.7 macrophage-like cells, thus 
indicating that MGHA scaffolds did not induce apoptosis in this 
cell type which presented apoptosis levels lower than 3 %. 
Table II. Effect of MGHA scaffolds (SC) on proliferation and 
apoptosis of RAW-264.7 macrophage-like cells. 
Sample Proliferation (Cell 
number x 10-3) 
Apoptosis (%) 
Control 32.2 ± 6.2 2.81 ± 0.14 
SC 30.5 ± 4.4 2.57 ± 0.13 
 
 When Confocal Microscopy techniques were carried out to 
evaluate the RAW-264.7 morphology in contact with MGHA 
disks, the typical characteristics of these macrophages were 
observed. Fig. 6 shows that no morphological alterations 
induced by MGHA material were detected in RAW-264.7 
macrophage-like cells which showed intact cytoplasmic 
filaments of F-actin (Fig. 6, FITC phalloidin labeling in green). 
DAPI is a DNA dye widely used to visualize the changes of the 
chromatin in apoptotic cells. This probe stains the cell nuclei 
and allows detecting the presence of apoptotic bodies produced 
by the chromatin condensation/fragmentation as a late marker 
of apoptosis. No apoptotic nuclei were detected in RAW-264.7 
macrophage-like cells cultured on MGHA disks in agreement 
with the low levels of apoptosis detected by flow cytometry 
(Table II). 
 The effects of 24h and 7d MGHA extracts and scaffolds on 
the cell size and complexity of RAW-264.7 macrophage-like 
cells were also evaluated by Flow Cytometry through FSC and 
90º SSC light scatter as indicators of cell size and complexity, 
respectively. These properties are determined in part by cell 
size, plasma membrane, cytoplasm, mitochondria, pinocytic 
vesicles, and lysosomes.35 As it can be observed in Fig. 7, the 
contact of RAW-264.7 macrophage-like cells with MGHA 
scaffolds or their extracts produce a decrease of cell size (Fig. 
7A) with a slight increase of macrophage complexity (Fig. 7B). 
 
Fig. 6 Morphological evaluation of RAW-264.7 macrophage-like 
cells on MGHA disks. Cells were stained with DAPI for the 
visualization of the cell nuclei in blue and with FITC phalloidin for the 
visualization of cytoplasmic F-actin filaments in green. 
 
Fig. 7 Effect of MGHA extracts and MGHA scaffolds on light 
scattering properties of RAW-264.7 macrophage-like cells. (A) 
Forward angle scatter (FSC, cell size) versus number of cells after 
treatment with MGHA scaffolds (green), 24 h extract (pink), and 7 d 
extract (blue). (B) 90 side angle light scatter (SSC, internal complexity) 
versus number of cells after treatment with MGHA scaffolds (green), 
24 h extract (pink), and 7 d extract (blue).Control cells without 
treatment (black). 
 Macrophages are one of the most versatile type of immune 
cells, carrying out a large number of important functions, 
essential to both innate and acquired immune responses. These 
functions include: phagocytosis of apoptotic cells, bacteria, and 
viruses; production of reactive nitrogen and oxygen species; 
antigen processing and presentation; and cytokine and 
chemokine production.15 Since reactive oxygen species (ROS) 
A 
B 
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and Ca2+ constitute the most important intracellular signaling 
molecules for the regulation and integration of diverse cellular 
functions, the effects of MGHA extracts (obtained at 24h and 
7d) and MGHA scaffolds (SC) on intracellular ROS content 
and cytosolic calcium of RAW-264.7 macrophage-like cells 
after 24h treatment were evaluated by flow cytometry with the 
probes DCFH and Indo-1 respectively. Significant ROS 
increases (p< 0.005) were produced by 7d MGHA extracts and 
scaffolds (Table III, a.u. = arbitrary units of fluorescence). 
Concerning intracellular calcium measurements, the probe 
Indo-1shifts their spectral characteristics upon calcium binding, 
from FL1 to FL2;36 ratio FL1/FL2 can be used as an indicator 
of intracellular Ca2+ content. As it can be observed in Table III, 
fluorescence ratio of RAW-264.7 macrophage-like cells 
significantly increased (p<0.001) after culture with 24h and 7d 
MGHA extracts and scaffolds, thus indicating the MGHA 
extracts and scaffolds induced a significant cytosolic calcium 
increase of these cells. Several studies have demonstrated that 
some materials increase [Ca2+]i possibly through the entry of 
extracellular Ca2+ via Ca2+ channels in the plasma membrane, 
and activate the generation of ROS.37  
Table III. Effect of MGHA extracts and MGHA scaffolds on 
intracellular ROS content and intracellular calcium of RAW-264.7 
macrophage-like cells. 
Sample ROS (a.u.) Cai (FL1/FL2) 
Control 476 ± 23.8 1.70 ± 0.09 
E 24h 471 ± 23.6 2.47 ± 0.12 
E 7d 606 ± 30.3 2.36 ± 0.12 
SC 611 ± 30.6 2.45 ± 0.12 
 
      Macrophages play a central role in directing the host 
response to implanted biomaterials, including the inflammatory 
response and the reparative response with an M1 and M2 
phenotypic spectrum.17-22 Since several studies have 
demonstrated that M1 macrophages produce and secrete higher 
ROS levels than M2 cells,17,38 the effects of MGHA extracts or 
MGHA scaffolds on populations of RAW-264.7 macrophage-
like cells with low and high intracellular ROS content have 
been evaluated by Flow Cytometry in the present study. Fig. 8 
shows the profiles of cell number (counts) versus DCF 
fluorescence (FL1) used as indicative of intracellular ROS. 
Macrophages in contact with MGHA scaffolds (Fig. 8B) and 
control macrophages (Fig. 8A) showed different intracellular 
ROS profiles. Fig. 9 shows that in the presence of 24h extracts, 
the population with low ROS content is significantly higher 
than the population with high ROS content, in agreement with 
the results presented in Table III which indicates no high 
intracellular ROS levels when RAW macrophage-like cells are 
cultured with these extracts. This effect can be related to the 
rapid release of ions (calcium, phosphorous and silicon) to the 
medium in the early steps of the reactivity/bioactivity process 
(Fig. 4). On the other hand, 7d MGHA extract does not induce 
changes on the percentages of low and high ROS populations 
probably due to the stabilization of this release which is slower 
at this time (Fig. 4). The direct contact of RAW-264.7 
macrophage-like cells with the MGHA scaffolds during 24h 
increases both the intracellular ROS content (Table III) and 
subsequently the high ROS content population in comparison 
with control, thus indicating the high reactivity/bioactivity of 
the surface-level of MGHA scaffolds previously observed in 
Fig. 3 and Fig. 4.  
 
 
Fig. 8 Effect of MGHA scaffolds on populations of RAW-264.7 
macrophage-like cells evaluated through intracellular ROS (Flow 
Cytometry profiles). Intracellular ROS (FL1, a.u.) versus number of 
cells after treatment with MGHA scaffolds (B). Control untreated cells 
(A). 
Fig. 9 Effect of MGHA extracts and MGHA scaffolds on the 
percentage of populations of RAW-264.7 macrophage-like cells 
with low and high intracellular ROS content. CTL = Control 
untreated cells. Columns with different letters are statistically different. 
Statistical significance ** ρ < 0.01; *** ρ < 0.005. 
3.3. Effects of MGHA biomaterial on murine spleen cell 
suspensions 
Immune response plays a determinant role in the tolerance to 
and functioning of biomaterials. Immune system is composed 
of many different subpopulations which mutually interact and 
cross-talk determining the final outcome of the immune 
response. To assess the potential effect of MGHA on immune 
cells, we chose to analyze its effect on murine spleen cell 
suspensions, an in vitro system in which different 
untransformed normal cell subpopulations interact in among 
them, better resembling the in vivo ambient. The spleen is a 
lymphoid organ which contains different types of immune cells, 
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mainly including T- and B-lymphocytes (about 80% in the 
mouse spleen), macrophages and other antigen-presenting 
(APC) (about 10%) and natural killer (NK) cells. These cells 
circulate through the body monitoring for signals which trigger 
an innate response or detecting non-self antigens, thus 
becoming activated, differentiated and expanded, mounting an 
acquired immune response. The contact of body fluids and 
blood cells with biomaterials may trigger the activation of 
granulocytes, monocytes and macrophages, driving to an acute 
and lately chronic inflammatory response. Although the 
biomaterial composition does not allow T cell activation via 
antigen presentation, it has been suggested that synthetic 
biomaterials may present functional groups on their surfaces 
acting as mitogens which can trigger lymphocytes by cross-
linking of glycoproteins on the cell surface.15 We assessed this 
possibility studying the effect of MGHA extracts and scaffolds 
on murine normal and activated immune cells.  
3.3.1. MGHA biomaterial does not alter murine lymphocyte 
activation or spontaneous apoptosis. To evaluate the 
biocompatibility of MGHA on murine spleen immune cells, we 
firstly assayed the in vitro effect of 24h biomaterial extracts, 
analysing any potential cytotoxic or immunomodulatory effect 
of the biomaterial components released to the medium. The 
MGHA extracts were added to cell suspensions of murine 
spleen cells in an in vitro activation assay in the absence or the 
presence of anti-CD3 antibody (5 µg/ml) or LPS (25 µg/ml) as 
mitogens. Cell activation was measured 72h later as 
mitochondrial activity (Fig. 10). Cell subpopulations became 
activated and proliferated in the presence of these stimuli, while 
cells in the control cultures (CTL) did not, even when MGHA 
extracts had been added to the cultures, indicating that no 
mitogen activity for immune cells is present in this biomaterial 
extract. No significant modification of cell activation was 
detected in control or mitogen-treated cultures in the presence 
of MGHA extracts. This assay also shows that the viability in 
the cultures was not modified in the presence of different 
proportions of MGHA extracts. We further analyzed the effect 
of MHGA-lymphoid cell contact by studying apoptosis of 
different lymphoid subpopulations in the presence of MGHA 
scaffolds. Spleen cells were seeded onto scaffolds and 
incubated during 24h before analyzing spontaneous apoptosis.  
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Fig. 10 Effect of MGHA extracts on murine spleen cell activation. 
The effect of two different concentrations of MGHA extract was 
evaluated in an activation assay in the presence of anti-CD3 antibody 
(YCD3-1, T-cell mitogen, squares), LPS (B-cell mitogen, triangles) or 
medium (control, CTL, inverted triangle). Mitochondrial activity was 
measured after 72 hours culture and represented as O.D.  
Fig. 11 shows that no significant modification  of spontaneous 
apoptosis (p>0.05 in all cases) was induced by MGHA 
scaffolds in T (CD3+, CD4+, CD8+) or B (CD19+) lymphocytes, 
natural killer (NK1.1+, GR1+, CD11b+) or monocytes-
macrophages (CD11b+) subpopulations in the spleen cell 
cultures. GR1 is also a marker for the low proportion of 
peripheral granulocytes found in the spleen which did not result 
affected by MGHA in this assay. 
 
Fig. 11 MGHA scaffolds do not affect spontaneous apoptosis of 
different spleen cell subpopulations. Apoptosis was measured as 
percent of AnnexinV+Propidium Iodide- cells by FACS in murine 
spleen cells which were seeded onto MGHA scaffolds (filled bars) or 
directly in the culture wells (CTL, empty bars) and cultured overnight.  
3.3.2. MGHA biomaterial does not affect the 
subpopulations balance or cytokine expression in activated 
murine immune cells. Activation of normal resting 
lymphocytes promotes their differentiation to different 
phenotypes of effector subpopulations and expression of 
specific cytokines. In T lymphocytes and macrophages co-
culture it has been found that T cells are attached 
predominantly to macrophages and not to the biomaterial 
surface, promoting macrophage adhesion and fusion via 
paracrine effects mediated by different cytokines.39 To further 
study the potential effect of the biomaterial in these processes 
we analyzed the effect of MGHA scaffolds in the balance of 
lymphoid subpopulations (measured by specific surface 
markers) and cytokine secretion (measured as intracellular 
interleukin expression). Fig. 12A shows that the frequency of 
different T cells subpopulations was not significantly altered by 
the presence of MGHA scaffold during the activation process 
mediated by T cell stimulus (anti-CD3 antibody) on spleen cells 
cultures. The frequency of total T cells (CD3+), helper (CD4+) 
or cytotoxic (CD8+) was evaluated. T activated cells were 
identified by CD25 and/or ICOS markers, in total T or in 
among CD4+ or CD8+ subpopulations showing no significant 
alteration of these subpopulations mediated by MGHA 
scaffolds. The use of a higher concentration of YCD3-1 (10 
µg/ml) for activation did not yield a different effect of the 
biomaterial extracts (data not shown). Natural 
CD4+CD25+Foxp3+ T regulatory cells play a very important 
role in controlling activation and effector functions of different 
lymphoid cells, and a disbalance in this subpopulation may 
cause lymphoproliferative and inflammatory disorders. Thus, 
we also analyzed the potential effect of MGHA scaffolds on T 
regulatory cells, but the frequency of natural Treg in activated 
cultures was not changed in the presence of MGHA scaffolds 
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(Fig. 12A). The potential effect of MGHA scaffolds was also 
assessed in LPS-stimulated spleen cells. Again, the frequency 
of B lymphocytes (CD19+), macrophages (CD11b+) or ICOS-
ligand expressing cells remained unaltered in the presence of 
MGHA as shown in Fig. 12B. The use of a higher 
concentration of LPS (50 µg/ml) for activation did not yield a 
different effect of the biomaterial extracts (data not shown). 
 
 
Fig. 12. MGHA scaffolds do not affect the subpopulations in a 
murine spleen cells activation assay. Percentage of different spleen 
cell subpopulations (indicated in the X axis) was evaluated by FACS 
analysis after 72 hours culture under T- (anti-CD3 antibody) (A) or B-
cell stimulus (LPS) (B) in the presence (filled bars) or absence (CTL, 
empty bars) of MGHA scaffolds. 
Cytokine expression and secretion constitute an important 
effector mechanism of immune cells, determining subsequent 
activation or suppression of other subpopulations. In among 
them, we chose to analyse IL-2, IL-10, IFNγ and TNFα because 
of their important implication in the immune response and 
inflammation. IL-2 is a Th1 cytokine that plays a central role in 
the activation, proliferation and differentiation of Ag-primed T 
lymphocytes.40,41 It also modulates the expression of IFNγ and 
MHC antigens, stimulates proliferation and differentiation of 
activated B cells and augments NK cell activity. IL-10 is an 
anti-inflammatory Th2 cytokine that has a critical role in 
limiting the immune response to prevent host damage.42 It is 
expressed by Th2, Th17, T regulatory and B cells, as well as 
innate immune cells as dendritic cells, macrophages, mast cells, 
NK, eosinophils and neutrophils. As IL-10 is produced in 
several T helper populations, it is proposed that it provides a 
feedback loop to limit the effector function of macrophages and 
dendritic cells. IFN-γ (Type-II Interferon) is produced by 
activated T, B and NK cells. During infection is produced by 
cytotoxic CD8+ T cells and Th1, inhibiting the proliferation of 
Th2 phenotype subpopulation. IFNγ acts in synergy with other 
cytokines including TNFα to inhibit the proliferation of normal 
or transformed cells but also activates monocytes, 
macrophages, NK and neutrophils. IFNγ is a marker for a 
number of different pathological situations including infections, 
autoimmune diseases, transplant rejection and diabetes.43,44  
TNF-α (Tumor Necrosis Factor alpha) is a pleiotropic cytokine 
that plays a role in innate and adaptive immunity.45 Though it is 
widely implicated in numerous immune responses and 
regulations, it is most often associated with regulation of cell 
survival and pro-inflammatories properties which lead to the 
recruitment and activation of inflammatory cells to the site of 
injury where it is known to induce various cytokines, including 
IL-1, IL-6, IL-8, MCP-1 and RANTES. TNF-α is primarily 
expressed by macrophages, but also by activated lymphocytes, 
NK cells and neutrophils in among others. It is associated with 
numerous inflammatory illnesses and autoimmunity. To 
analyze the potential secondary effect of MGHA on immune 
cells we studied the intracellular expression of IL-2, IL-10, 
IFN-γ or TNF-α in spleen cell cultures which were activated by 
mitogens during 72h. Cytokine expression was analysed in total 
spleen cells or CD3+ or CD19+ subpopulations. No significant 
effect (p>0.05) of MGHA scaffolds on the intracellular 
cytokine expression was detected in the analysed cell 
populations under T- (Fig. 13A) or APC-activating conditions 
(Fig. 13B). The absence of significant changes in IL-2 and 
IFNγ expression in the presence of the scaffolds indicates the 
lack of MGHA effects on T cells (Fig. 13). In parallel the 
absence of significant changes in TNF-α or IL-10 expression 
indicates that pro- or anti-inflammatory loops are not 
significantly modified by MGHA scaffolds in T- or APC-
stimuli conditions (Fig. 13A and B). 
 
 
Fig. 13. MGHA biomaterial does not affect the cytokine expression 
in activated murine immune cells.  Percent of cytokine positive 
spleen cells (indicated in the X axis) was evaluated by FACS analysis 
after 72 hours culture under T- (anti-CD3 antibody) (A) or B-cell 
stimulus (LPS) (B) in the presence (filled bars) or absence (CTL, empty 
bars) of MGHA scaffolds. 
Adjuvant properties of mesoporous silica nanoparticles have 
been recently shown in several experimental models, producing 
different effects which depend on the size and functionalization 
of the particles.46-48 In this sense, amino-functionalized MCM-
41 (AM-41) has been used as a vaccine delivery vehicle and 
adjuvant in mice using ovalbumin as a model protein antigen.48  
AM-41 nanoparticles showed adjuvant behaviour and elicited 
immune responses at reduced antigen doses in vivo. However, 
there were no local or systemic negative effects in animals 
injected with AM-41.48 In the present study, MGHA scaffolds 
do not stimulate a significant inflammatory response in vitro. 
The absence of MGHA immunogenic activity might be 
explained considering the morphology of the samples (which 
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are scaffolds and not nanoparticles) and the different evaluation 
models. 
4. Conclusions 
Some modifications are induced by MGHA nanocomposite on 
RAW macrophage-like cells after contact with the scaffold 
surface or with 24h extracts, which can be related to the high 
reactivity/bioactivity of this nanocomposite. However, MGHA 
material does not produce significant in vitro alterations in the 
activation of macrophages, B- or T-lymphocytes and natural 
killer cells when an immune response stimulation model was 
carried out using murine primary immune cell subpopulations. 
Since the MGHA scaffolds are good supports for adhesion, 
proliferation and differentiation of preosteoblasts, and they 
would not stimulate a significant inflammatory response, the 
present study supports the biocompatibility of MGHA material 
and suggests an adequate host tissue response to their scaffolds 
upon their implantation.  
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